11:54 AM
May 04, 2017
 |  BC Extra  |  Financial News

Gene therapy newco Vivet raises €37.5M

Vivet Therapeutics (Paris, France), a newco developing gene therapies, raised €37.5 million ($40.8 million) in a series A round led by Novartis Venture Fund and Columbus Venture Partners. Also participating were Roche Venture Fund, HealthCap, Kurma Partners and Ysios Capital.

In 2018, the company...

Read the full 205 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >